Dr. Charles L. Knupp, MD

Dr. Knupp practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Knupp's NPI, 1154313575, was assigned on August 22, 2005. Dr. Knupp graduated from University of Maryland School of Medicine in 1976. Dr. Knupp holds North Carolina license 24433.

Dr. Knupp's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Dr. Knupp's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. The medical group on file is ECU Health. Dmand AI also links Dr. Knupp to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Knupp practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Knupp's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Knupp is board certified in hematology by the American Board of Internal Medicine. Dr. Knupp is licensed in North Carolina.

CMS data shows 397 Medicare services from Dr. Knupp across 5 procedure codes in 2024, for 197 Medicare patients. Medicare paid $28,949 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Dr. Knupp in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Knupp's median patient age at 71, with 60% women.

In 2024, Dr. Knupp wrote 968 Medicare Part D claims for 100 patients. 77% of them were for generic drugs. CMS names the drug for 779 of them, across 26 drugs with 11 or more claims each, at $1,375,537 in total drug cost. In 2023, CMS named 806 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Knupp for performance year 2024, reported through an alternative payment model (APM). Dr. Knupp accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Knupp, published from 2012 to 2016. 2013 was the busiest year, with 3. The most frequent topics are Anemia, Sickle Cell. Dr. Knupp's most frequent co-authors are Darla Kaye Liles, MD, Kenneth I. Ataga, MD and Sai Hemanth Chavala, MD.

CMS Open Payments shows 94 general payments to Dr. Knupp from 33 drug and device companies from 2016 to 2024. Accredited education speaker fees make up the largest share, 98% of the total. Pfizer Inc. paid the most, $71,694.

Dr. Knupp graduated from University of Maryland School of Medicine in 1976.